| pubmed-article:2070367 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:2070367 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:2070367 | lifeskim:mentions | umls-concept:C0006055 | lld:lifeskim |
| pubmed-article:2070367 | lifeskim:mentions | umls-concept:C0949445 | lld:lifeskim |
| pubmed-article:2070367 | lifeskim:mentions | umls-concept:C1959633 | lld:lifeskim |
| pubmed-article:2070367 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:2070367 | pubmed:dateCreated | 1991-8-22 | lld:pubmed |
| pubmed-article:2070367 | pubmed:abstractText | We report the results of electromyographic (EMG) guidance in the treatment of cervical dystonia with botulinum toxin. Eight-four patients received a total of 225 injection sessions. Overall there was moderate objective improvement in 78.7%. The mean dose of toxin was 269 +/- 39 mouse lethal units and the mean duration of maximum effect was 107 +/- 49 days. Complications included excessive neck weakness in 16.0% and dysphagia in 11.1% of the injection sessions. We conclude that EMG guidance is a safe and effective method of administering botulinum toxin in the treatment of cervical dystonia. | lld:pubmed |
| pubmed-article:2070367 | pubmed:language | eng | lld:pubmed |
| pubmed-article:2070367 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2070367 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:2070367 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2070367 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:2070367 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:2070367 | pubmed:issn | 0362-5664 | lld:pubmed |
| pubmed-article:2070367 | pubmed:author | pubmed-author:KollerW CWC | lld:pubmed |
| pubmed-article:2070367 | pubmed:author | pubmed-author:GrayC SCS | lld:pubmed |
| pubmed-article:2070367 | pubmed:author | pubmed-author:DubinskyR MRM | lld:pubmed |
| pubmed-article:2070367 | pubmed:author | pubmed-author:Vetere-Overfi... | lld:pubmed |
| pubmed-article:2070367 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:2070367 | pubmed:volume | 14 | lld:pubmed |
| pubmed-article:2070367 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:2070367 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:2070367 | pubmed:pagination | 262-7 | lld:pubmed |
| pubmed-article:2070367 | pubmed:dateRevised | 2010-11-18 | lld:pubmed |
| pubmed-article:2070367 | pubmed:meshHeading | pubmed-meshheading:2070367-... | lld:pubmed |
| pubmed-article:2070367 | pubmed:meshHeading | pubmed-meshheading:2070367-... | lld:pubmed |
| pubmed-article:2070367 | pubmed:meshHeading | pubmed-meshheading:2070367-... | lld:pubmed |
| pubmed-article:2070367 | pubmed:meshHeading | pubmed-meshheading:2070367-... | lld:pubmed |
| pubmed-article:2070367 | pubmed:meshHeading | pubmed-meshheading:2070367-... | lld:pubmed |
| pubmed-article:2070367 | pubmed:meshHeading | pubmed-meshheading:2070367-... | lld:pubmed |
| pubmed-article:2070367 | pubmed:meshHeading | pubmed-meshheading:2070367-... | lld:pubmed |
| pubmed-article:2070367 | pubmed:meshHeading | pubmed-meshheading:2070367-... | lld:pubmed |
| pubmed-article:2070367 | pubmed:meshHeading | pubmed-meshheading:2070367-... | lld:pubmed |
| pubmed-article:2070367 | pubmed:year | 1991 | lld:pubmed |
| pubmed-article:2070367 | pubmed:articleTitle | Electromyographic guidance of botulinum toxin treatment in cervical dystonia. | lld:pubmed |
| pubmed-article:2070367 | pubmed:affiliation | Department of Neurology, University of Kansas Medical Center, Kansas City 66103. | lld:pubmed |
| pubmed-article:2070367 | pubmed:publicationType | Journal Article | lld:pubmed |
